Your browser doesn't support javascript.
loading
Accelerating Global Deletion of the Abnormal Toxicity Test for vaccines and biologicals. Planning common next steps. A workshop Report.
Viviani, Laura; Reid, Kirsty; Gastineau, Thierry; Milne, Catherine; Smith, Dean; Levis, Robin; Lei, Dianliang; van Ooij, Mark; Gilbert, Philippe Alexandre; Vandeputte, Joris; Xie, Jianxun; Madhuri, Leena; Shaid, Shahjahan; Kubiak, Vaughn; Suri, Rajinder; Mizukami, Takuo; Shirasaki, Yoshihisa; Li, Xiantang; Zhou, Ying-Ying; Trapkova, Alla; Goel, Sunil; Prakash, Jai; Subagio, Amrullah Aninditio; Suwarni, Eniek; Jung, Kyung Jin; Sanyal, Gautam; Das, Pradip; Coppens, Emmanuelle; Wright, David; Peng, Zhechu; Northeved, Helle; Jungbäck, Carmen; Kirpitchenok, Tatiana; Del Pace, Lorenzo; Seo, Borami; Poojary, Brinda; Ottoni, Antoniana.
Affiliation
  • Viviani L; Humane Society International, Switzerland. Electronic address: lviviani@hsi.org.
  • Reid K; European Federation of Pharmaceutical Industry and Association, Belgium.
  • Gastineau T; Sanofi Pasteur, France.
  • Milne C; European Directorate for the Quality of Medicine and HealthCare (EDQM), France.
  • Smith D; Health Canada, Canada.
  • Levis R; Food and Drug Administration, USA.
  • Lei D; World Health Organization, Switzerland.
  • van Ooij M; Janssen, the Netherlands.
  • Gilbert PA; Bill & Melinda Gates Foundation, USA.
  • Vandeputte J; International Alliance for Biological Standardization, France.
  • Xie J; Janssen, China.
  • Madhuri L; Indian Immunologicals, India.
  • Shaid S; GlaxoSmith Kline, Germany.
  • Kubiak V; International Alliance for Biological Standardization, France.
  • Suri R; Developing Countries Vaccine Manufacturers Network, India.
  • Mizukami T; National Institute of Infectious Diseases, Japan.
  • Shirasaki Y; GlaxoSmith Kline, Japan.
  • Li X; Pfizer, China.
  • Zhou YY; Meck, USA.
  • Trapkova A; Federal State Budgetary Institution 'Scientific Centre for Expert Evaluation of Medicinal Products' of the Ministry of Health, Russian Federation.
  • Goel S; Serum Institute of India, India.
  • Prakash J; Indian Pharmacopoeia Committee, India.
  • Subagio AA; BioFarma, Indonesia.
  • Suwarni E; Food and Drug Administration, Indonesia.
  • Jung KJ; Korea Institute of Toxicology, South Korea.
  • Sanyal G; Vaccine Analytics LLC, USA.
  • Das P; Biological E, India.
  • Coppens E; Sanofi Pasteur, France.
  • Wright D; Pfizer, USA.
  • Peng Z; Boehringer Ingelheim, USA.
  • Northeved H; Lundbeck, Denmark.
  • Jungbäck C; International Alliance for Biologicals Standardization, France.
  • Kirpitchenok T; European Federation of Pharmaceutical Industry and Association, Belgium.
  • Del Pace L; Humane Society International, Italy.
  • Seo B; Humane Society International, South Korea.
  • Poojary B; Humane Society International, India.
  • Ottoni A; Humane Society International, Brazil.
Biologicals ; 78: 17-26, 2022 Jul.
Article in En | MEDLINE | ID: mdl-35840492
ABSTRACT
This online workshop Accelerating Global Deletion of the Abnormal Toxicity Test for vaccines and biologicals. Planning common next steps was organized on October 14th, 2021, by the Animal Free Safety Assessment Collaboration (AFSA), the Humane Society International (HSI), the European Federation of Pharmaceutical Industries and Associations (EFPIA), in collaboration with the International Alliance of Biological Standardization (IABS). The workshop saw a participation of over a hundred representatives from international organizations, pharmaceutical industries and associations, and regulatory authorities of 28 countries. Participants reported on country- and region-specific regulatory requirements and, where present, on the perspectives on the waiving and elimination of the Abnormal Toxicity Test. With AFSA, HSI, EFPIA and IABS representatives as facilitators, the participants also discussed specific country/global actions to further secure the deletion of ATT from all regulatory requirements worldwide.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / Toxicity Tests Limits: Humans Language: En Journal: Biologicals Journal subject: ALERGIA E IMUNOLOGIA Year: 2022 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / Toxicity Tests Limits: Humans Language: En Journal: Biologicals Journal subject: ALERGIA E IMUNOLOGIA Year: 2022 Type: Article